Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 826, pseudogene (RN7SL826P)

Target
RN7SL826P
Molecular classification
Other (Pseudogene, non-coding RNA)
01

Overview

RN7SL826P (RNA, 7SL, cytoplasmic 826, pseudogene) is a human pseudogene—a non-functional genomic locus derived from the *7SL RNA* gene, which is the RNA component of the signal recognition particle (SRP)[1][5]. SRP is essential for the targeting and translocation of nascent proteins to the endoplasmic reticulum in eukaryotic cells[4]. However, RN7SL826P itself is classed as a pseudogene: it does not encode a functional RNA or protein product and is not known to participate in cellular processes or have a disease association[1][5]. Most of the hundreds of *7SL RNA*-like sequences in the human genome are inactive pseudogenes generated by reverse flow of information from 7SL RNA to DNA—these generally lack detectable transcription and biological function[5]. As a consequence, RN7SL826P is neither a therapeutically relevant target nor a functional component in signaling, enzymatic, or regulatory pathways. Note: - RN7SL826P should NOT be confused with the functional *7SL RNA* (component of signal recognition particle), which is active in protein targeting and translocation[3][4]. - There is no evidence that this pseudogene is related to disease, used as a biomarker, or modulated by drugs[1][5]. Summary of issues: - This entry is a non-functional pseudogene, not a therapeutic target, receptor, or enzyme[1][5]. - No known molecular function, biological role, or involvement in disease. Sources: [1][4][5]

Other names
RN7SL826PRNA, 7SL, cytoplasmic 826, pseudogene

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 826, pseudogene (RN7SL826P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 826, pseudogene (RN7SL826P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call